Laverock Therapeutics raised €23.3m in seed funding led by Calculus Capital, joined by Eli Lilly, Mercia Ventures, Eos Advisory, Maven Capital and Norcliffe.
01 June 2025
01 June 2025
Total investments received (USD): 43.99M
Round value (USD): 26.84M
Company: Laverock Therapeutics
Related deals
Paid in a $21.6 million seed round led by Lightspeed, joined by FUSE and existing investor EQT Ventures
Investments
18 September 2025
Mimica raised a $26.2 million Series B round led by Paladin Capital Group, with Khosla Ventures, LGVP, and Entrepreneurs First
Investments
14 September 2025
Synthesized in a $20M Series A funding round led by redalpine, with participation from IQ Capital, Mercia Ventures, UBS, and Seedcamp.
Investments
14 September 2025
Alchemab raised $32m in Series A extension funding from OVI, RA Capital, SV Health Investors, DCVC Bio , Lightstone Ventures, and Eli Lilly.
Investments
03 September 2025
Fyxer raised a $30m Series B led by Madrona, with participation from Lakestar.
Investments
01 September 2025
Belgium
Netherlands
Austria
Germany
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
France
Ireland
Italy
Portugal
Spain